ENVOY MEDICAL, INC. Increase (Decrease) in Accounts Payable
ENVOY MEDICAL, INC. (COCH) reported Increase (Decrease) in Accounts Payable of -$912.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $308.00K.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.22M, a 12300.00% decline year-over-year.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $412.00K.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.01M, a 498.81% increase year-over-year.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for fiscal 2023 was $551.00K, a 61.11% increase from fiscal 2022.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for fiscal 2022 was $342.00K, a 44.66% decline from fiscal 2021.
- ENVOY MEDICAL, INC. increase (decrease) in accounts payable for fiscal 2021 was $618.04K.
| Period end | Increase (Decrease) in Accounts Payable 0 month | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $308.00K derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10 | -$912.00K 10-Q · filed 2026-08-10 | -$500.00K derived: sum of 3 quarters · filed 2026-08-10 | $506.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | -$1.22M POS AM · filed 2026-06-12 | -$808.00K derived: sum of 2 quarters · filed 2026-06-12 | $198.00K derived: sum of 3 quarters · filed 2026-06-12 | $155.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | $412.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $1.42M derived: sum of 2 quarters · filed 2026-06-12 | $1.38M derived: sum of 3 quarters · filed 2026-08-10 | $1.39M POS AM · filed 2026-06-12 | |||||
| 2025-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $963.00K derived: sum of 2 quarters · filed 2026-08-10 | $973.00K 10-Q · filed 2025-11-10 | $751.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | -$43.00K derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10 | -$33.00K 10-Q · filed 2026-08-10 | -$255.00K derived: sum of 3 quarters · filed 2026-08-10 | -$87.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | $10.00K POS AM · filed 2026-06-12 | -$212.00K derived: sum of 2 quarters · filed 2026-06-12 | -$44.00K derived: sum of 3 quarters · filed 2026-06-12 | $632.00K derived: sum of 4 quarters · filed 2026-06-12 | |||||
| 2024-12-31 | -$222.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | -$54.00K derived: sum of 2 quarters · filed 2026-06-12 | $622.00K derived: sum of 3 quarters · filed 2026-06-12 | -$19.00K POS AM · filed 2026-06-12 | |||||
| 2024-09-30 | $168.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $844.00K derived: sum of 2 quarters · filed 2025-11-10 | $203.00K 10-Q · filed 2025-11-10 | -$1.62M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $35.00K 10-Q · filed 2025-07-31 | -$1.79M derived: sum of 3 quarters · filed 2025-07-31 | -$771.00K derived: sum of 4 quarters · filed 2025-07-31 | |||||
| 2024-03-31 | -$641.00K 10-Q · filed 2025-05-01 | -$2.47M derived: sum of 2 quarters · filed 2025-05-01 | -$1.45M derived: sum of 3 quarters · filed 2025-05-01 | -$1.11M derived: sum of 4 quarters · filed 2025-05-01 | |||||
| 2023-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$806.00K derived: sum of 2 quarters · filed 2025-03-31 | -$467.00K derived: sum of 3 quarters · filed 2025-03-31 | $551.00K 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.36M derived: sum of 2 quarters · filed 2024-11-14 | $2.38M 10-Q · filed 2024-11-14 | $2.96M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $339.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.36M 10-Q · filed 2024-08-12 | $254.03K 10-Q · filed 2023-08-14 | $1.94M derived: sum of 3 quarters · filed 2024-08-12 | $1.43M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $1.02M 10-Q · filed 2024-05-15 | $388.28K 10-Q · filed 2023-05-15 | $1.60M derived: sum of 2 quarters · filed 2024-05-15 | $1.09M derived: sum of 3 quarters · filed 2024-05-15 | $1.32M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $583.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | $76.15K derived: sum of 2 quarters · filed 2024-04-01 | $301.84K derived: sum of 3 quarters · filed 2024-04-01 | $342.00K 10-K · filed 2024-04-01 | $558.80K 10-K · filed 2023-04-03 | ||||
| 2022-09-30 | -$506.85K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-01-17 | -$281.16K derived: sum of 2 quarters · filed 2024-01-17 | -$241.00K 10-Q/A · filed 2024-01-17 | $452.60K 10-Q · filed 2022-11-14 | -$422.38K derived: sum of 4 quarters · filed 2024-01-17 | ||||
| 2022-06-30 | $225.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $265.85K 10-Q · filed 2023-08-14 | $84.46K derived: sum of 3 quarters · filed 2023-08-14 | $830.72K derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $40.16K 10-Q · filed 2023-05-15 | -$141.23K derived: sum of 2 quarters · filed 2023-05-15 | $605.03K derived: sum of 3 quarters · filed 2023-05-15 | $671.27K derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | -$181.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-03 | $564.87K derived: sum of 2 quarters · filed 2023-04-03 | $631.11K derived: sum of 3 quarters · filed 2023-04-03 | $618.04K 10-K · filed 2023-04-03 | |||||
| 2021-09-30 | $746.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $812.49K derived: sum of 2 quarters · filed 2022-11-14 | $799.42K 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | $66.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $53.17K 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | -$13.07K 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |